Alectinib Exposure Lower With Low-Fat Yogurt Intake
WEDNESDAY, June 14, 2023 (HealthDay News) — For patients with advanced anaplastic lymphoma kinase-positive non-small cell lung cancer, alectinib exposure is lower when taken with low-fat yogurt, according to a study published in the June issue of the…
Learn MoreAdolescent Residential Addiction Facilities Largely Do Not Provide Buprenorphine
WEDNESDAY, June 14, 2023 (HealthDay News) — Only one in four U.S. facilities offer buprenorphine for adolescent residential addiction treatment, according to a research letter published in the June 13 issue of the Journal of the American Medical Asso…
Learn MoreNew Threshold Could Inform Rabies Postexposure Prophylaxis Decisions
TUESDAY, June 13, 2023 (HealthDay News) — A newly defined risk threshold may inform decision-making for the appropriateness of rabies postexposure prophylaxis, according to a study published online June 9 in JAMA Network Open.Kelly Charniga, Ph.D., f…
Learn MoreFixed-Duration Ibrutinib Plus Venetoclax Beneficial for Leukemia
TUESDAY, June 13, 2023 (HealthDay News) — Fixed-duration ibrutinib plus venetoclax is beneficial for patients with chronic lymphocytic leukemia, including those with high risk features, according to a study published online June 7 in Clinical Cancer …
Learn MoreOutpatient Metformin Treatment Reduces Incidence of Long COVID
MONDAY, June 12, 2023 (HealthDay News) — Outpatient treatment with metformin reduces the incidence of long COVID, especially when started within three days of symptom onset, according to a study published online June 8 in The Lancet Infectious Diseas…
Learn MoreValbenazine Yields Improvement in Chorea in Huntington Disease
MONDAY, June 12, 2023 (HealthDay News) — Valbenazine results in improvement in chorea compared with placebo for patients with Huntington disease, according to a study published in the June issue of The Lancet Neurology.Erin Furr-Stimming, M.D., from …
Learn MoreASCO: Adding Atezolizumab to Cabozantinib No Benefit in Advanced Renal Cancer
FRIDAY, June 9, 2023 (HealthDay News) — For patients with locally advanced or metastatic renal cell carcinoma with disease progression on or after immune checkpoint inhibitor treatment, the addition of atezolizumab to cabozantinib does not improve cl…
Learn MoreASCO: Cilta-Cel Beneficial for Lenalidomide-Refractory Multiple Myeloma
THURSDAY, June 8, 2023 (HealthDay News) — For patients with lenalidomide-refractory multiple myeloma, a single cilta-cel infusion results in lower risk of disease progression or death compared with standard care, according to a study published online…
Learn MoreASCO: Drug Combo Ups Progression-Free Survival for Metastatic Prostate Cancer
THURSDAY, June 8, 2023 (HealthDay News) — For patients with metastatic castration-resistant prostate cancer (mCRPC), talazoparib plus enzalutamide results in improvement in radiographic progression-free survival (rPFS), according to a study published…
Learn MoreSemaglutide Reduces BMI Category for Adolescents With Obesity
WEDNESDAY, June 7, 2023 (HealthDay News) — For adolescents with obesity, semaglutide is effective for reducing body mass index (BMI) category, according to a study published online May 17 in Obesity.Aaron S. Kelly, Ph.D., from the University of Minne…
Learn More